Citizen Portal
Sign In

Get Full Government Meeting Transcripts, Videos, & Alerts Forever!

Get email alerts on the Public Health Kratom topic

No spam. Unsubscribe anytime.

Legislative committee urges state and federal action after local testimony on concentrated kratom products

Legislative Program Committee, Santa Barbara County · March 3, 2026
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.

Summary

The Santa Barbara County Legislative Program Committee voted to support federal scheduling and press for stronger state regulation of concentrated kratom products after public testimony describing addiction and local health concerns. County staff will coordinate comments and further county-level actions.

The Legislative Program Committee of Santa Barbara County voted March 2 to back federal scheduling and to press California lawmakers for stronger regulations after hearing emotional testimony from local families and medical experts about concentrated kratom products commonly referenced in testimony as “70.”

Committee members said the public-health risks and enforcement gaps warrant county advocacy at both levels of government. Craig Abby, whose son spoke to the committee, said his family’s experience persuaded him to ask for the strongest possible action: “my son Arland who got addicted to 70 pills,” Abby said, describing a period of severe withdrawal and repeated hospital care.

Why it matters: testimony and public-health staff described a product-category confusion between crude kratom leaf (marketed as a supplement) and much more potent concentrated extracts that behave pharmacologically like opioids. County Health Department clinicians and a University physician who testified to the committee reported respiratory-depression risks and difficulty treating withdrawal, raising enforcement and prevention concerns for local public-health and law-enforcement agencies.

What the committee did: committee members voted to direct staff to (a) endorse federal scheduling work being pursued through FDA/DEA rulemaking, (b) support state-level consumer-protection legislation (including AB1088 currently in the Senate), and (c) coordinate with County Health to draft county-level options, including ordinance language and a vendor list for enforcement and public education. Dr. Hami of County Health told the committee that statewide guidance is needed because local enforcement capacity is limited and roles remain unclear.

Public comment shaped the decision: multiple residents and one young person who described lived addiction experiences urged a ban or strong regulation; witnesses also stressed the need for funding and enforcement capacity if local bans or restrictions are adopted. Committee members emphasized that letters of support can request stronger language than currently in some bills and that the county should work with other jurisdictions pursuing outright bans.

Next steps: staff will coordinate with County Health to assemble enforcement options and prepare letters for federal and state officials urging robust action. The committee also asked staff to compile a seller list from tobacco-regulated vendors as a first step to focusing local enforcement and outreach.

The committee’s vote was a direction to staff rather than adoption of a local ordinance; follow-up actions will be brought back to the full Board for consideration.